Thomas C. Sodeman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas C. Sodeman has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- William A. Sodeman
Professor Emeritus, Department of Medicine, Medical University of Ohio, Lecturer in Law, University of Toledo, College of Law, Toledo, Ohio
75 shared publications - Abhinav Tiwari
Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USA
3 shared publications Ali Nawras
Department of Gastroenterology, University of Toledo Medical Center, Toledo, OH, USA
3 shared publicationsHimani Sharma
Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USA
3 shared publicationsKhola Qamar
Department of Gastroenterology, University of Toledo Medical Center, Toledo, OH, USA
3 shared publications- Muhammad Ali Khan
Division of Gastroenterology and Hepatology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Profound Hyperbilirubinemia During Severe Carbon Monoxide Poisoning and Subsequent Multiorgan Failure: A Case Report
Carbon monoxide poisoning is classically associated with neurologic and cardiovascular toxicity, while severe exposure may also cause systemic toxic‐hypoxic injury. Profound direct‐predominant hyperbilirubinemia without mechanical biliary obstruction is rarely described. We report a 55‐year‐old woman with alcohol use disorder, chronic tobacco use, COPD, and hepatic steatosis who presented with altered mental status and jaundice after suspected household carbon monoxide exposure. Her carboxyhemoglobin level was > 30%, and she required intubation, intensive care, vasopressor support, and three hyperbaric oxygen treatments. Initial testing showed total bilirubin of 23.1 mg/dL and direct bilirubin of 13.1 mg/dL, despite only mild AST elevation and near‐normal ALT and alkaline phosphatase. Imaging showed hepatic steatosis and cholelithiasis without convincing biliary obstruction, and the documented workup for viral, autoimmune, metabolic, hemolytic, and vascular causes was unrevealing. Her liver dysfunction was considered multifactorial, with possible carbon monoxide‐related toxic‐hypoxic injury superimposed on underlying steatotic or alcohol‐related liver vulnerability. After transient improvement, she developed coagulopathy, acute kidney injury, recurrent shock with clinical and imaging concern for acute cholecystitis, worsening hyperbilirubinemia peaking near 49–50 mg/dL, encephalopathy, respiratory failure, and multiorgan failure. Cholecystostomy yielded dark green bile without documented purulence, and aspirate cultures showed no growth; biliary sepsis was therefore not microbiologically confirmed. She died in the hospital after goals‐of‐care discussions. The initial bilirubin‐predominant pattern was atypical for classic hypoxic hepatitis and may have reflected overlapping hepatic insults. This case emphasizes broad evaluation and cautious causal interpretation; it does not establish that carbon monoxide exposure alone caused the initial hyperbilirubinemia.
- 6 November 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (11)
Open AccessProfound Hyperbilirubinemia During Severe Carbon Monoxide Poisoning and Subsequent Multiorgan Failure: A Case Report
Carbon monoxide poisoning is classically associated with neurologic and cardiovascular toxicity, while severe exposure may also cause systemic toxic‐hypoxic injury. Profound direct‐predominant hyperbilirubinemia without mechanical biliary obstruction is rarely described. We report a 55‐year‐old woman with alcohol use disorder, chronic tobacco use, COPD, and hepatic steatosis who presented with altered mental status and jaundice after suspected household carbon monoxide exposure. Her carboxyhemoglobin level was > 30%, and she required intubation, intensive care, vasopressor support, and three hyperbaric oxygen treatments. Initial testing showed total bilirubin of 23.1 mg/dL and direct bilirubin of 13.1 mg/dL, despite only mild AST elevation and near‐normal ALT and alkaline phosphatase. Imaging showed hepatic steatosis and cholelithiasis without convincing biliary obstruction, and the documented workup for viral, autoimmune, metabolic, hemolytic, and vascular causes was unrevealing. Her liver dysfunction was considered multifactorial, with possible carbon monoxide‐related toxic‐hypoxic injury superimposed on underlying steatotic or alcohol‐related liver vulnerability. After transient improvement, she developed coagulopathy, acute kidney injury, recurrent shock with clinical and imaging concern for acute cholecystitis, worsening hyperbilirubinemia peaking near 49–50 mg/dL, encephalopathy, respiratory failure, and multiorgan failure. Cholecystostomy yielded dark green bile without documented purulence, and aspirate cultures showed no growth; biliary sepsis was therefore not microbiologically confirmed. She died in the hospital after goals‐of‐care discussions. The initial bilirubin‐predominant pattern was atypical for classic hypoxic hepatitis and may have reflected overlapping hepatic insults. This case emphasizes broad evaluation and cautious causal interpretation; it does not establish that carbon monoxide exposure alone caused the initial hyperbilirubinemia.
- Open Access
- 14 May 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 331 (2) , G262-G276
Elevated Circulating Bile Acids Driven Erythrocyte Osmotic Resistance Marks Hepatobiliary Disease
Cholemia, i.e., elevated circulating bile acids (BA), is an early feature of hepatobiliary disorders. However, cholemia often goes undetected because BA are not measured in routine health screenings. We hypothesized that the membrane-disrupting properties of BA might impact red blood cell (RBC) osmotic resistance (OR), potentially providing a means to detect cholemia. To test this, RBC OR was examined in multiple mouse models of cholemia, germ-free animals, and patients with cholestatic liver disease. RBC from cholemic mice exhibited markedly elevated OR against hypotonic NaCl, KCl and NH 4 Cl solutions. Elevated OR was observed in an array of mouse models of cholemia, including mice with spontaneous portosystemic shunts, deficiencies in aryl hydrocarbon receptor, multidrug resistance protein 2 and farnesoid X receptor. The degree of OR correlated with serum BA levels. RBC OR increased upon ex vivo treatment with cholemic plasma or unconjugated BA. Conversely, the absence of gut microbiota in germ-free animals was associated with reduced BA levels and decreased RBC OR. Colonizing gut microbiota into germ-free animals via co-housing increased their RBC OR. RBC from patients with cholestatic liver disease also displayed increased OR, indicating potential human relevance. The elevated cholesterol-to-phospholipid ratio in the membranes of RBC from both cholemic mice and humans suggests increased membrane rigidity. Consistent with this, treatment with dimethyl sulfoxide to enhance membrane permeability reduced RBC OR. Taken together, these findings provide proof-of-concept that increased RBC OR is associated with cholemia and may serve as a basis for a whole-blood approach to its detection.
- 14 May 2026
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 331 (2) , G262-G276
Open AccessElevated Circulating Bile Acids Driven Erythrocyte Osmotic Resistance Marks Hepatobiliary Disease
Cholemia, i.e., elevated circulating bile acids (BA), is an early feature of hepatobiliary disorders. However, cholemia often goes undetected because BA are not measured in routine health screenings. We hypothesized that the membrane-disrupting properties of BA might impact red blood cell (RBC) osmotic resistance (OR), potentially providing a means to detect cholemia. To test this, RBC OR was examined in multiple mouse models of cholemia, germ-free animals, and patients with cholestatic liver disease. RBC from cholemic mice exhibited markedly elevated OR against hypotonic NaCl, KCl and NH 4 Cl solutions. Elevated OR was observed in an array of mouse models of cholemia, including mice with spontaneous portosystemic shunts, deficiencies in aryl hydrocarbon receptor, multidrug resistance protein 2 and farnesoid X receptor. The degree of OR correlated with serum BA levels. RBC OR increased upon ex vivo treatment with cholemic plasma or unconjugated BA. Conversely, the absence of gut microbiota in germ-free animals was associated with reduced BA levels and decreased RBC OR. Colonizing gut microbiota into germ-free animals via co-housing increased their RBC OR. RBC from patients with cholestatic liver disease also displayed increased OR, indicating potential human relevance. The elevated cholesterol-to-phospholipid ratio in the membranes of RBC from both cholemic mice and humans suggests increased membrane rigidity. Consistent with this, treatment with dimethyl sulfoxide to enhance membrane permeability reduced RBC OR. Taken together, these findings provide proof-of-concept that increased RBC OR is associated with cholemia and may serve as a basis for a whole-blood approach to its detection.
- Open Access
- 30 June 2025
- Published by University of Toledo in Translation: The University of Toledo Journal of Medical Sciences
- Vol. 13 (S3)
Assessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review
Translation: The University of Toledo Journal of Medical Sciences is the online journal launched by the University of Toledo. Manuscripts will be considered on the understanding that they report original work and are not under consideration for publication by any other journal. The journal publishes original articles reporting experimental results of basic or clinical research, case reports, and reviews. The journal uses a single blind peer review system and each manuscript, based on the results presented in its original submission, will be evaluated by two student reviewers and one faculty reviewer. This process will provide an opportunity for medical students, graduate students, residents, fellows and faculty to publish research observation in a timely manner.
- 30 June 2025
- Published by University of Toledo in Translation: The University of Toledo Journal of Medical Sciences
- Vol. 13 (S3)
Open AccessAssessing GLP-1 RAs in Diabetic Gastroparesis: A Literature Review
Translation: The University of Toledo Journal of Medical Sciences is the online journal launched by the University of Toledo. Manuscripts will be considered on the understanding that they report original work and are not under consideration for publication by any other journal. The journal publishes original articles reporting experimental results of basic or clinical research, case reports, and reviews. The journal uses a single blind peer review system and each manuscript, based on the results presented in its original submission, will be evaluated by two student reviewers and one faculty reviewer. This process will provide an opportunity for medical students, graduate students, residents, fellows and faculty to publish research observation in a timely manner.
- Open Access
- 13 March 2018
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 4 (1) , e10
Improving Internal Medicine Residents’ Colorectal Cancer Screening Knowledge Using a Smartphone App: Pilot Study
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- 13 March 2018
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 4 (1) , e10
Open AccessImproving Internal Medicine Residents’ Colorectal Cancer Screening Knowledge Using a Smartphone App: Pilot Study
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- Open Access
- 11 December 2017
- Published by JMIR Publications Inc. in JMIR Preprints
Improving Internal Medicine Residents Colorectal Cancer Screening Knowledge Using a Smartphone App: Pilot Study (Preprint)
BACKGROUND Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer death in the United States. About one in three adults in the United States is not getting the CRC screening as recommended. Internal medicine residents are deficient in CRC screening knowledge. OBJECTIVE The objective of our study was to assess the improvement in internal medicine residents’ CRC screening knowledge via a pilot approach using a smartphone app. METHODS We designed a questionnaire based on the CRC screening guidelines of the American Cancer Society, American College of Gastroenterology, and US Preventive Services Task Force. We emailed the questionnaire via a SurveyMonkey link to all the residents of an internal medicine department to assess their knowledge of CRC screening guidelines. Then we designed an educational intervention in the form of a smartphone app containing all the knowledge about the CRC screening guidelines. The residents were introduced to the app and asked to download it onto their smartphones. We repeated the survey to test for changes in the residents’ knowledge after publication of the smartphone app and compared the responses with the previous survey. We applied the Pearson chi-square test and the Fisher exact test to look for statistical significance. RESULTS A total of 50 residents completed the first survey and 41 completed the second survey after publication of the app. Areas of CRC screening that showed statistically significant improvement (P<.05) were age at which CRC screening was started in African Americans, preventive tests being ordered first, identification of CRC screening tests, identification of preventive and detection methods, following up positive tests with colonoscopy, follow-up after colonoscopy findings, and CRC surveillance in diseases. CONCLUSIONS In this modern era of smartphones and gadgets, developing a smartphone-based app or educational tool is a novel idea and can help improve residents’ knowledge about CRC screening.
- 11 December 2017
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImproving Internal Medicine Residents Colorectal Cancer Screening Knowledge Using a Smartphone App: Pilot Study (Preprint)
BACKGROUND Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer death in the United States. About one in three adults in the United States is not getting the CRC screening as recommended. Internal medicine residents are deficient in CRC screening knowledge. OBJECTIVE The objective of our study was to assess the improvement in internal medicine residents’ CRC screening knowledge via a pilot approach using a smartphone app. METHODS We designed a questionnaire based on the CRC screening guidelines of the American Cancer Society, American College of Gastroenterology, and US Preventive Services Task Force. We emailed the questionnaire via a SurveyMonkey link to all the residents of an internal medicine department to assess their knowledge of CRC screening guidelines. Then we designed an educational intervention in the form of a smartphone app containing all the knowledge about the CRC screening guidelines. The residents were introduced to the app and asked to download it onto their smartphones. We repeated the survey to test for changes in the residents’ knowledge after publication of the smartphone app and compared the responses with the previous survey. We applied the Pearson chi-square test and the Fisher exact test to look for statistical significance. RESULTS A total of 50 residents completed the first survey and 41 completed the second survey after publication of the app. Areas of CRC screening that showed statistically significant improvement (P<.05) were age at which CRC screening was started in African Americans, preventive tests being ordered first, identification of CRC screening tests, identification of preventive and detection methods, following up positive tests with colonoscopy, follow-up after colonoscopy findings, and CRC surveillance in diseases. CONCLUSIONS In this modern era of smartphones and gadgets, developing a smartphone-based app or educational tool is a novel idea and can help improve residents’ knowledge about CRC screening.
- Open Access
- 4 October 2017
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2017, 1-4
The Traumatic Tube: Bleeding Rectal Ulcer Caused by Flexi-Seal Device
Diarrhea and fecal incontinence are common in critically ill patients and present a challenging problem in patient management. The Flexi-Seal® Fecal Management System is a device to divert the stools away from the patient, thus improving the care to patients with fecal incontinence. There have been only few case reports describing the complications with the use of this device. Here, we present a case of a 77-year-old woman who was admitted due to massive hematochezia while on anticoagulation. She was found to have a large rectal ulcer caused by the Flexi-Seal device, used during the last hospital stay for fecal incontinence. Flexi-Seal device can be effective for the management of incontinence; however, caution should be exercised during handling and pressure from the retention balloon should be relieved periodically.
- 4 October 2017
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2017, 1-4
Open AccessThe Traumatic Tube: Bleeding Rectal Ulcer Caused by Flexi-Seal Device
Diarrhea and fecal incontinence are common in critically ill patients and present a challenging problem in patient management. The Flexi-Seal® Fecal Management System is a device to divert the stools away from the patient, thus improving the care to patients with fecal incontinence. There have been only few case reports describing the complications with the use of this device. Here, we present a case of a 77-year-old woman who was admitted due to massive hematochezia while on anticoagulation. She was found to have a large rectal ulcer caused by the Flexi-Seal device, used during the last hospital stay for fecal incontinence. Flexi-Seal device can be effective for the management of incontinence; however, caution should be exercised during handling and pressure from the retention balloon should be relieved periodically.
- Open Access
- 26 September 2017
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 11 (3) , 554-558
Unusual Clinical Presentation of Hemobilia with Recurrent Vasovagal Episodes
Hemobilia is caused by the abnormal connection between a blood vessel and the bile duct, which is usually iatrogenic and caused by hepatobiliary procedures. The classic triad of hemobilia includes biliary colic, obstructive jaundice, and gastrointestinal bleeding. We present the case of an 80-year-old man who had laparoscopic cholecystectomy complicated by hemobilia. He had an unusual presentation of hemobilia in the form of transient vasovagal episodes in addition to abdominal pain and hematochezia.
- 26 September 2017
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 11 (3) , 554-558
Open AccessUnusual Clinical Presentation of Hemobilia with Recurrent Vasovagal Episodes
Hemobilia is caused by the abnormal connection between a blood vessel and the bile duct, which is usually iatrogenic and caused by hepatobiliary procedures. The classic triad of hemobilia includes biliary colic, obstructive jaundice, and gastrointestinal bleeding. We present the case of an 80-year-old man who had laparoscopic cholecystectomy complicated by hemobilia. He had an unusual presentation of hemobilia in the form of transient vasovagal episodes in addition to abdominal pain and hematochezia.
- Open Access
- 2 May 2017
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 11 (1) , 256-264
Recognition of Extraperitoneal Colonic Perforation following Colonoscopy: A Review of the Literature
Colon perforation is an uncommon but serious complication of colonoscopy. It may occur as either intraperitoneal or extraperitoneal perforation or in combination. The majority of colonic perforations are intraperitoneal, causing air and intracolonic contents to leak into the peritoneal space. Rarely, colonic perforation can be extraperitoneal, leading to the passage of air into the retroperitoneal space causing pneumoretroperitoneum, pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema. A literature review revealed that 31 cases of extraperitoneal perforation exist, out of which 20 cases also reported concomitant intraperitoneal perforation. We report the case of a young female with a history of ulcerative colitis who developed combined intraperitoneal and extraperitoneal perforation after colonoscopy. We also report the duration of onset of symptoms, clinical features, imaging findings, site of leak, and treatment administered in previously reported cases of extraperitoneal colonic perforation.
- 2 May 2017
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 11 (1) , 256-264
Open AccessRecognition of Extraperitoneal Colonic Perforation following Colonoscopy: A Review of the Literature
Colon perforation is an uncommon but serious complication of colonoscopy. It may occur as either intraperitoneal or extraperitoneal perforation or in combination. The majority of colonic perforations are intraperitoneal, causing air and intracolonic contents to leak into the peritoneal space. Rarely, colonic perforation can be extraperitoneal, leading to the passage of air into the retroperitoneal space causing pneumoretroperitoneum, pneumomediastinum, pneumopericardium, pneumothorax, and subcutaneous emphysema. A literature review revealed that 31 cases of extraperitoneal perforation exist, out of which 20 cases also reported concomitant intraperitoneal perforation. We report the case of a young female with a history of ulcerative colitis who developed combined intraperitoneal and extraperitoneal perforation after colonoscopy. We also report the duration of onset of symptoms, clinical features, imaging findings, site of leak, and treatment administered in previously reported cases of extraperitoneal colonic perforation.
- Open Access
- 1 January 2014
- Published by Hindawi Limited in Canadian Journal of Gastroenterology and Hepatology
- Vol. 28 (8) , 434-438
Efficacy and Safety of, and Patient Satisfaction with, Colonoscopic-Administered Fecal Microbiota Transplantation in Relapsing and Refractory Community- and Hospital-Acquired Clostridium difficile Infection
OBJECTIVE: To report the efficacy and safety of, and patient satisfaction with, colonoscopic fecal microbiota transplantation (FMT) for community- and hospital-acquired Clostridium difficile infection (CDI).METHODS: A retrospective medical records review of patients who underwent FMT between July 1, 2012 and August 31, 2013 was conducted. A total of 22 FMTs were performed on 20 patients via colonoscopy. The patients were divided into ‘community-acquired’ and ‘hospital-acquired’ CDI. Telephone surveys were conducted to determine procedure outcome and patient satisfaction. Primary cure rate was defined as resolution of diarrhea without recurrence within three months of FMT, whereas secondary cure rate described patients who experienced resolution of diarrhea and return of normal bowel function after a second course of FMT.RESULTS: Nine patients met the criteria for community-acquired CDI whereas 11 were categorized as hospital-acquired CDI. A female predominance in the community-acquired group (88.89% [eight of nine]) was found (P=0.048). The primary cure rate was 100% (nine of nine) and 81.8% (nine of 11 patients) in community- and hospital-acquired CDI groups, respectively (P=0.189). Two patients in the hospital-acquired group had to undergo a repeat FMT for persistent symptomatic infection; the secondary cure rate was 100%. During the six-month follow-up, all patients were extremely satisfied with the procedure and no complications or adverse events were reported.CONCLUSION: FMT was a highly successful and very acceptable treatment modality for treating both community- and hospital-acquired CDI.
- 1 January 2014
- Published by Hindawi Limited in Canadian Journal of Gastroenterology and Hepatology
- Vol. 28 (8) , 434-438
Open AccessEfficacy and Safety of, and Patient Satisfaction with, Colonoscopic-Administered Fecal Microbiota Transplantation in Relapsing and Refractory Community- and Hospital-Acquired Clostridium difficile Infection
OBJECTIVE: To report the efficacy and safety of, and patient satisfaction with, colonoscopic fecal microbiota transplantation (FMT) for community- and hospital-acquired Clostridium difficile infection (CDI).METHODS: A retrospective medical records review of patients who underwent FMT between July 1, 2012 and August 31, 2013 was conducted. A total of 22 FMTs were performed on 20 patients via colonoscopy. The patients were divided into ‘community-acquired’ and ‘hospital-acquired’ CDI. Telephone surveys were conducted to determine procedure outcome and patient satisfaction. Primary cure rate was defined as resolution of diarrhea without recurrence within three months of FMT, whereas secondary cure rate described patients who experienced resolution of diarrhea and return of normal bowel function after a second course of FMT.RESULTS: Nine patients met the criteria for community-acquired CDI whereas 11 were categorized as hospital-acquired CDI. A female predominance in the community-acquired group (88.89% [eight of nine]) was found (P=0.048). The primary cure rate was 100% (nine of nine) and 81.8% (nine of 11 patients) in community- and hospital-acquired CDI groups, respectively (P=0.189). Two patients in the hospital-acquired group had to undergo a repeat FMT for persistent symptomatic infection; the secondary cure rate was 100%. During the six-month follow-up, all patients were extremely satisfied with the procedure and no complications or adverse events were reported.CONCLUSION: FMT was a highly successful and very acceptable treatment modality for treating both community- and hospital-acquired CDI.
- 2 January 2005
- Published by Elsevier
- p. 65-66
Shoes and Falls